Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression
2024; Elsevier BV; Volume: 162; Linguagem: Inglês
10.1016/j.metabol.2024.156051
ISSN1532-8600
AutoresAdrien Vouilloz, Thibaut Bourgeois, Marc Diedisheim, Thomas Pilot, Antoine Jalil, Naïg Le Guern, Victoria Bergas, Noéline Rohmer, Florence Castelli, Damien Leleu, Alexis Varin, Jean-Paul Paı̈s de Barros, Pascal Degrace, Mickaël Rialland, Camille Blériot, Nicolas Venteclef, Charles Thomas, David Masson,
Tópico(s)Diet, Metabolism, and Disease
ResumoAlthough qualitative and quantitative alterations in liver Polyunsaturated Fatty Acids (PUFAs) are observed in MASH in humans, a causal relationship of PUFAs biosynthetic pathways is yet to be clarified. ELOVL5, an essential enzyme in PUFA elongation regulates hepatic triglyceride metabolism. Nonetheless, the long-term consequences of elongase disruption, particularly in murine models of MASH, have not been evaluated.
Referência(s)